Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Myers

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
AIDS Education and Prevention : Official Publication of the International Society for AIDS Education|December 22, 2025
Prevalence and Patterns of Substance Use Among Sexual and Gender Minority Young Adults Assigned Male at Birth and Their Relationship With Mental Health ProblemsJoseph Belloir, Thomas Myers, Thomas Scherr, et al.
Wilderness & Environmental Medicine|February 12, 2020
Wilderness Medical Society Clinical Practice Guidelines for the Management of Exercise-Associated Hyponatremia: 2019 UpdateBrad L Bennett, Tamara Hew-Butler, Mitchell H Rosner, et al.
The Journal of Arthroplasty|May 30, 2015
Early Postoperative Outcomes of Primary Total Knee Arthroplasty After Solid Organ Transplantation in the United States, 1998-2011Alison K Klika, Thomas Myers, Caleb R Szubski, et al.
Nanoscale|September 3, 2022
Magnetic particles for triggering insulin release in INS-1E cells subjected to a rotating magnetic fieldSvetlana Ponomareva, Helene Joisten, Taina François, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2008
Phase I trial using proteasome inhibitor bortezomib and concurrent temozolomide and radiotherapy for central nervous system malignanciesGregory J Kubicek, Maria Werner-Wasik, Mitchell Machtay, et al.
Breast Cancer Research and Treatment|April 16, 2019
Correction to: Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancerJangsoon Lee, Bora Lim, Troy Pearson, et al.
Breast Cancer Research and Treatment|March 4, 2019
Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancerJangsoon Lee, Bora Lim, Troy Pearson, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
AIDS Education and Prevention : Official Publication of the International Society for AIDS Education|December 22, 2025
Prevalence and Patterns of Substance Use Among Sexual and Gender Minority Young Adults Assigned Male at Birth and Their Relationship With Mental Health ProblemsJoseph Belloir, Thomas Myers, Thomas Scherr, et al.
Wilderness & Environmental Medicine|February 12, 2020
Wilderness Medical Society Clinical Practice Guidelines for the Management of Exercise-Associated Hyponatremia: 2019 UpdateBrad L Bennett, Tamara Hew-Butler, Mitchell H Rosner, et al.
The Journal of Arthroplasty|May 30, 2015
Early Postoperative Outcomes of Primary Total Knee Arthroplasty After Solid Organ Transplantation in the United States, 1998-2011Alison K Klika, Thomas Myers, Caleb R Szubski, et al.
Nanoscale|September 3, 2022
Magnetic particles for triggering insulin release in INS-1E cells subjected to a rotating magnetic fieldSvetlana Ponomareva, Helene Joisten, Taina François, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2008
Phase I trial using proteasome inhibitor bortezomib and concurrent temozolomide and radiotherapy for central nervous system malignanciesGregory J Kubicek, Maria Werner-Wasik, Mitchell Machtay, et al.
Breast Cancer Research and Treatment|April 16, 2019
Correction to: Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancerJangsoon Lee, Bora Lim, Troy Pearson, et al.
Breast Cancer Research and Treatment|March 4, 2019
Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancerJangsoon Lee, Bora Lim, Troy Pearson, et al.
Pageof 2